Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Medcalf

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Current Drug Targets|June 29, 2011
Plasminogen activation-based thrombolysis for ischaemic stroke: the diversity of targets may demand new approachesRobert L Medcalf
The FEBS Journal|September 24, 2005
Meet the serpinsRobert L Medcalf
British Journal of Pharmacology|June 2, 2011
Desmoteplase: discovery, insights and opportunities for ischaemic strokeRobert L Medcalf
Methods in Enzymology|June 21, 2011
Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulationRobert L Medcalf
Blood|April 18, 2015
The traumatic side of fibrinolysisRobert L Medcalf
Frontiers in Immunology|April 17, 2020
Editorial: Fibrinolysis in ImmunityKrasimir Kolev, Robert L Medcalf
Journal of Visualized Experiments : Jove|December 5, 2013
Improved method for the preparation of a human cell-based, contact model of the blood-brain barrierBe'eri Niego, Robert L Medcalf
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 5, 2014
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?Be'eri Niego, Robert L Medcalf
Frontiers in Immunology|November 3, 2023
Editorial: Thrombosis meets inflammationKrasimir Kolev, Robert L Medcalf
Blood|March 18, 2021
Plasminogen: an enigmatic zymogenCharithani B Keragala, Robert L Medcalf
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Current Drug Targets|June 29, 2011
Plasminogen activation-based thrombolysis for ischaemic stroke: the diversity of targets may demand new approachesRobert L Medcalf
The FEBS Journal|September 24, 2005
Meet the serpinsRobert L Medcalf
British Journal of Pharmacology|June 2, 2011
Desmoteplase: discovery, insights and opportunities for ischaemic strokeRobert L Medcalf
Methods in Enzymology|June 21, 2011
Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulationRobert L Medcalf
Blood|April 18, 2015
The traumatic side of fibrinolysisRobert L Medcalf
Frontiers in Immunology|April 17, 2020
Editorial: Fibrinolysis in ImmunityKrasimir Kolev, Robert L Medcalf
Journal of Visualized Experiments : Jove|December 5, 2013
Improved method for the preparation of a human cell-based, contact model of the blood-brain barrierBe'eri Niego, Robert L Medcalf
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 5, 2014
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?Be'eri Niego, Robert L Medcalf
Frontiers in Immunology|November 3, 2023
Editorial: Thrombosis meets inflammationKrasimir Kolev, Robert L Medcalf
Blood|March 18, 2021
Plasminogen: an enigmatic zymogenCharithani B Keragala, Robert L Medcalf
Pageof 12